logo

For the Inventor, By the Inventor

Ballerup, Denmark

Xifu Liang

USPTO Granted Patents = 17 

 

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 29(Granted Patents)


Location History:

  • Frederiksberg, DK (2006)
  • Glostrup, DK (2011 - 2017)
  • Ballerup, DK (2015 - 2022)

Company Filing History:

goldMedal10 out of 33 
 
Leo Laboratories Limited
 patents
silverMedal7 out of 67 
 
Leo-pharma A/s
 patents

Years Active: 2006-2022

Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents
1. 11377425 - Small molecule modulators of IL-17 (2022-07-05),
2. 11065257 - Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors (2021-07-20),
3. 10906915 - Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors (2021-02-02),
4. 10793580 - Substituted pyrazoloazepin-8-ones and their use as phosphodiesterase inhibitors (2020-10-06),
5. 9708286 - Ingenol-3-acylates III and ingenol-3-carbamates (2017-07-18),
6. 9676698 - Method of producing ingenol-3-angelate (2017-06-13),
7. 9656945 - 3-acyl-ingenols II (2017-05-23),
8. 9624157 - Process for the preparation of ingenol-3-angelate from 20-deoxy-ingenol (2017-04-18),
9. 9422309 - 3-O-heteroaryl-ingenol (2016-08-23),
10. 9416084 - Method of producing ingenol-3-angelate (2016-08-16),
11. 9404131 - Process for the preparation of ingenol-3-angelate (2016-08-02),
12. 9388124 - Ingenol-3-acylates I (2016-07-12),
13. 9102687 - Ingenol-3-acylates III and ingenol-3-carbamates (2015-08-11),
14. 8901356 - Method of producing ingenol-3-angelate (2014-12-02),
15. 8350026 - VEGF-2 receptor and protein tyrosine kinase inhibitors and pharmaceutical use thereof (2013-01-08),

Title: Xifu Liang: Innovator in Pharmaceutical Chemistry

Introduction

Xifu Liang is a prominent inventor based in Ballerup, Denmark, known for his significant contributions to pharmaceutical chemistry. With a total of 17 patents to his name, he has made remarkable advancements in the field of medicinal compounds.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Small molecule modulators of IL-17." This invention relates to a compound according to formula I and pharmaceutically acceptable salts, hydrates, or solvates thereof. The invention further encompasses the use of these compounds in therapy, pharmaceutical compositions comprising said compounds, methods of treating diseases, particularly dermal diseases, and their application in the manufacture of medicaments. Another notable patent is for "Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors." This invention introduces novel substituted pyrazoloazepin-4-ones with phosphodiesterase inhibitory activity, which are utilized as therapeutic agents in treating inflammatory diseases and conditions.

Career Highlights

Xifu Liang has worked with esteemed companies such as Leo Laboratories Limited and Leo Pharma A/S. His work in these organizations has significantly contributed to the development of innovative therapeutic solutions.

Collaborations

He has collaborated with notable colleagues, including Thomas Högberg and Gunnar Grue-Sørensen, enhancing the impact of his research and inventions.

Conclusion

Xifu Liang's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a leading innovator in the field. His work continues to influence the development of new therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…